In our latest DEIB Book Club meeting, we discussed Suleika Jaouad’s inspiring memoir, “Between Two Kingdoms.” Many Voracians agreed it was one of our most favorite reads yet, because we hold #AML so close to our hearts in everything we do. We are thankful to Suleika for sharing her experience and bringing awareness to the challenges of patients with AML.
Vor Bio
生物技术研究
Cambridge，Massachusetts 13,477 位关注者
Vor Bio's vision is to cure blood cancers through cell and genome engineering.
关于我们
Vor Bio is a clinical-stage cell and genome engineering company that aims to change the standard of care for patients with blood cancers by engineering hematopoietic stem cells to enable targeted therapies post-transplant.
- 网站
-
https://www.vorbio.com
Vor Bio的外部链接
- 所属行业
- 生物技术研究
- 规模
- 51-200 人
- 总部
- Cambridge，Massachusetts
- 类型
- 上市公司
地点
-
主要
获取路线
100 Cambridgepark Dr
Suite 101
US，Massachusetts，Cambridge，02140
Vor Bio员工
动态
-
This week, we continued our fundraising efforts for The Leukemia & Lymphoma Society and Lymphoma Society’s #LighttheNight with a raffle, custom crayons, and – what else – a special Ping Pong Tournament where employees’ donations added up to give players unique competitive disadvantages, including wearing eye patches and using pickleball paddles. Thanks to all who participated and congrats to our winners! So far, Voracians have raised more than $14,000! Learn more about our team: https://lnkd.in/eWAmRPwZ.
-
We’re proud to announce that #VorBio CEO, Dr. Robert Ang has been appointed 2025 Vice Chair of Alliance for Regenerative Medicine (ARM), the leading international advocacy organization championing the benefits of engineered cell therapies and genetic medicines. We are thankful to ARM for its leadership and advocacy in advancing new, innovative therapies for patients in need: https://lnkd.in/ecgyz_G4.
-
“We’re in a unique position to bridge research and manufacturing.” Chenlin (Lexie) Zhou, PhD, talks about what it’s like working on the Process Development team at #VorBio, the importance of collaboration, and how she works with teams across the company to improve the yield and quality of our clinical products.
-
Thanks to BiotechTV for visiting us at #VorBio today and discussing our novel approach to #AML treatment!
?????????????? ????????: Vor Bio is trying to help AML patients who receive a stem cell transplant to be more amenable to follow-on therapies. They just had key PoC data. President and CEO Robert Ang describes how Vor knocks out CD33 in transplant cells before they are administered so that patients can tolerate follow-on treatments like Mylotarg and CAR-T easier and earlier. He describes clinical data the company announced last month. Full video: https://lnkd.in/eHUjqipH BiotechTV is brought to you by: Mispro | Breakthrough Properties | HSBC Innovation Banking | Theragent Inc | NYSE | Allucent
-
Who gets the most out of mentorship programs, the mentee or the mentor??You might be surprised by Samir Vattompadam’s perspective! Read more here from #VorBio’s SVP of Portfolio Strategy and Program Management:
Senior Vice President @ Vor Bio | Executive Leadership, Portfolio Strategy and Program Management
Is Mentorship more impactful for the Mentor and Organization than the Mentee? If you have a mentorship program, get involved. If you don't, help start one. Here are my thoughts on how mentorship programs benefit the mentor, your company, and our industry in profound ways #mentorship #Vor Bio
-
We are excited to welcome Han Choi, M.D., LL.M. as #VorBio’s Chief Financial Officer. Han’s extensive experience in healthcare investment and strategic operations will help our team advance our mission of transforming outcomes for patients with AML and other blood cancers. Learn more about Han: https://lnkd.in/eBVidPPM.
-
Next week, #VorBio will discuss its novel approach combining shielded transplants with targeted therapies to treat #AML in a fireside chat at Chardan ’s 8th Annual Genetic Medicines Conference. Learn more: https://lnkd.in/e-hY8swp. #ChardanGMConf
-
Headed to #FierceBiotechSummit next week? #VorBio CEO, Robert Ang and VP of Corporate Communications & Investor Relations, Sarah Spencer, will host a fireside chat on the CEO-Comms partnership and what it takes to build success while navigating internal and external challenges in the current environment. Learn more: https://lnkd.in/gZiJ8nHE?
-